Objetivo
Bone is among the most frequently transplanted tissue with about 1 million procedures annually in Europe. The worldwide market of bone replacement materials is currently estimated at 5 billion € with a 10% annual growth. Despite their considerable disadvantages, including the risk of disease transfer and immunologic rejection, limited supply of bone, costs and complications, allografts and autografts account for more than 80% of total graft volume. Significant growth opportunities exist for synthetic bone grafts in association with mesenchymal stem cells from autologous or allogenic sources as alternatives to biological bone grafts in orthopaedic and maxillofacial surgery. The objectives of REBORNE is to perform clinical trials using advanced biomaterials and cells triggering bone healing in patients. In order to reach this goal, five phase II clinical studies with 20 patients are proposed in 12 clinical centres spread in 8 European countries. Three orthopaedic trials concerning the treatment of long bone fractures and osteonecrosis of the femoral head in adults or children will be conducted using bioceramics, hydrogel for percuteneous injection and stem cells from autologous or allogenic sources. Clinical research will also concern maxillofacial surgery with bone augmentation prior to dental implants and the reconstruction of cleft palates in children. The safety and efficacy of the new therapies will be assessed clinically using X-rays, CT scans and MRI as well as histology of biopsies. These ambitious clinical targets will require research and development efforts from a large consortium of top world class laboratories, SMEs manufacturing biomaterials, GMP-cell producing facilities and surgeons in hospitals as well as the consideration of ethical and regulatory issues. It is expected that REBORNE will expand the competitiveness of Europe through the patenting of new CE-marked bioproducts in the field of regenerative medicine.
Ámbito científico
Convocatoria de propuestas
FP7-HEALTH-2009-single-stage
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-IP - Large-scale integrating projectCoordinador
75654 Paris
Francia
Ver en el mapa
Participantes (23)
93210 La Plaine Saint Denis
Ver en el mapa
44360 Vigneux De Bretagne
Ver en el mapa
75015 PARIS 15
Ver en el mapa
20122 Milano
Ver en el mapa
La participación finalizó
44093 Nantes
Ver en el mapa
75012 Paris
Ver en el mapa
4040 HERSTAL
Ver en el mapa
3723 MB Bilthoven
Ver en el mapa
08034 Barcelona
Ver en el mapa
28049 Madrid
Ver en el mapa
41121 Modena
Ver en el mapa
300041 Timisoara
Ver en el mapa
37044 Tours Cedex 9
Ver en el mapa
72074 Tuebingen
Ver en el mapa
89081 Ulm
Ver en el mapa
37129 Verona
Ver en el mapa
75016 PARIS
Ver en el mapa
5020 Bergen
Ver en el mapa
3584 CX Utrecht
Ver en el mapa
40136 Bologna
Ver en el mapa
80539 Munchen
Ver en el mapa
50139 Firenze
Ver en el mapa
4000 Liege
Ver en el mapa